# Model Critique: Experiment 1 - Hierarchical Normal Model

**Date:** 2025-10-28
**Status:** ✅ **ACCEPTED** (conditional on Experiments 2 and 4)

---

## Quick Summary

The Hierarchical Normal Model (Experiment 1) has been comprehensively evaluated and **ACCEPTED** for baseline meta-analytic inference. All validation stages passed with strong performance across computational, statistical, and scientific dimensions.

**Bottom Line:**
- ✅ All falsification criteria passed
- ✅ Excellent validation (SBC: 94-95% coverage)
- ✅ Strong predictive performance (PPC: 9/9 test statistics pass)
- ✅ Adequate convergence (R-hat at boundary but well-supported)
- ✅ Scientific plausibility (effect size reasonable)
- ✅ No critical limitations requiring revision

**Recommendation:** Proceed to Experiments 2 (complete pooling comparison) and 4 (prior sensitivity testing) as planned.

---

## Documents in This Directory

### 1. `critique_summary.md` (MAIN DOCUMENT)
**Length:** ~15 pages (comprehensive)

**Contents:**
- Executive summary
- Scientific validity assessment (plausibility, domain consistency, effect size, actionability)
- Statistical adequacy assessment (assumptions, residuals, influence, uncertainty)
- Computational reliability assessment (convergence, ESS, sampling diagnostics)
- Model limitations and scope (what model can/cannot tell us)
- Comparison to alternative models (Experiments 2-5)
- Falsification criteria evaluation
- Overall adequacy decision
- Recommendations for next steps

**Key Findings:**
- Model is scientifically valid, statistically adequate, and computationally reliable
- No critical flaws detected, all diagnostics passed
- Small sample (J=8) limits precision but model handles appropriately
- Comparison to Experiments 2-4 is necessary for complete assessment

**Read this for:** Complete justification of ACCEPT decision with detailed evidence

---

### 2. `decision.md` (DECISION DOCUMENT)
**Length:** ~4 pages (concise)

**Contents:**
- Decision: ACCEPT (with conditions)
- Executive summary of decision
- Detailed justification (why ACCEPT, why not REVISE, why not REJECT)
- What ACCEPT means (and doesn't mean)
- Supported vs unsupported conclusions
- Required next steps (Experiments 2, 4)
- Conditional acceptance criteria

**Key Points:**
- ACCEPT does NOT mean perfect - means adequate for purpose
- Conditions reflect experiment plan requirements, not model inadequacy
- Must complete Experiments 2 and 4 before final conclusions
- Model provides baseline for comparison with alternatives

**Read this for:** Clear decision and justification in 1-page executive format

---

### 3. `improvement_priorities.md` (IF REVISION NEEDED)
**Length:** ~5 pages (reference)

**Contents:**
- Status: No immediate improvements required (ACCEPT decision)
- Categorized improvement opportunities:
  - Cannot fix (data limitations)
  - Already planned (Experiments 2-4)
  - Could improve but not needed
  - Extensions beyond scope
- Prioritized list (hypothetical, if revision were needed)
- Conditional improvements (if Experiments 2-4 reveal issues)

**Key Points:**
- Since ACCEPT, this is reference document (not action plan)
- Most "improvements" require more data, not model changes
- Experiments 2-4 already address main uncertainties
- DO NOT exclude Study 5 or artificially narrow CIs

**Read this for:** Context on what could be improved (hypothetically) and what NOT to do

---

## Decision Summary

### ACCEPT: Model is Adequate

**Rationale:**
- All validation stages passed (prior predictive, SBC, fitting, PPC, LOO)
- No falsification criteria met (tau < 15, k < 0.7, PPC pass, Study 4 not overly influential)
- Excellent calibration (94-95% SBC coverage)
- Strong predictive performance (all test statistics pass)
- Scientifically plausible (effect size reasonable, handles outliers appropriately)
- No critical limitations requiring revision

**Conditions:**
1. Must compare to Experiment 2 (complete pooling) - MANDATORY per plan
2. Must assess prior sensitivity (Experiment 4) - MANDATORY for J=8
3. Phase 4 synthesis must confirm no superior alternatives

**Interpretation:**
- ACCEPT means "fit for purpose," not "perfect"
- Model is valid baseline for comparison
- Inference is defensible, but comparison adds context
- Wide credible intervals reflect honest uncertainty (strength, not weakness)

---

## Key Findings

### Posterior Results

| Parameter | Mean | SD | 95% CI | Interpretation |
|-----------|------|-----|--------|----------------|
| **mu** (pooled mean) | 9.87 | 4.89 | [0.28, 18.71] | Average effect likely positive but uncertain |
| **tau** (between-study SD) | 5.55 | 4.21 | [0.03, 13.17] | Heterogeneity present but poorly estimated |
| **I²** (% heterogeneity) | 17.6% | 17.2% | [0.01%, 59.9%] | Low to moderate, huge uncertainty |

**Study-specific effects:** All shrunk 70-88% toward mu (appropriate given J=8 and high variance)

### Validation Results

| Stage | Status | Key Metric | Assessment |
|-------|--------|------------|------------|
| **Prior predictive** | ✅ PASS | Reasonable prior | Priors weakly informative |
| **SBC** | ✅ PASS | 94-95% coverage | Well-calibrated posteriors |
| **Convergence** | ✅ PASS | R-hat=1.01, ESS adequate | At boundary but supported |
| **Posterior predictive** | ✅ PASS | 9/9 test statistics | Excellent fit |
| **LOO** | ✅ PASS | All k < 0.7 | No problematic outliers |

### Scientific Interpretation

**What we can conclude:**
- Treatment effect is likely positive (97% posterior mass > 0)
- Magnitude is uncertain (95% CI [0.28, 18.71])
- Between-study heterogeneity exists but is poorly quantified
- Study-specific effects are uncertain and overlapping
- Study 5 (only negative) is most influential but accommodated adequately

**What we cannot conclude:**
- Precise heterogeneity (I² could be 0% or 60%)
- Which study is "best" (all CIs overlap)
- Whether complete pooling is adequate (requires Exp 2)
- Whether results are prior-sensitive (requires Exp 4)

---

## Falsification Criteria (All Passed)

From experiment plan:

| Criterion | Threshold | Observed | Pass/Fail |
|-----------|-----------|----------|-----------|
| 1. Posterior tau > 15 | tau > 15 | tau = 5.55 | ✅ PASS |
| 2. Multiple Pareto k > 0.7 | ≥2 studies | Max k = 0.647 | ✅ PASS |
| 3. PPC fails | p < 0.05 or > 0.95 | All p ∈ [0.29, 0.85] | ✅ PASS |
| 4. Study 4 >100% influence | k > 1.0 | k = 0.398 | ✅ PASS |
| 5. Prior predictive fails | Extreme 5% | Passed | ✅ PASS |

**Interpretation:** No red flags triggered. Model is not falsified.

---

## Required Next Steps

### 1. Experiment 2: Complete Pooling (MANDATORY)
**Purpose:** Test if heterogeneity matters (null hypothesis: tau = 0)
**Expected:** Similar mu, narrower CI, LOO comparison decides
**Timeline:** Immediate next step
**Effort:** 1-2 hours

### 2. Experiment 4: Prior Sensitivity (MANDATORY)
**Purpose:** Quantify sensitivity to prior choice (critical for J=8)
**Expected:** Low mu sensitivity, moderate tau sensitivity (2-4 units)
**Timeline:** After Experiments 1-2
**Effort:** 2-3 hours

### 3. Experiment 3: Robust Model (CONDITIONAL)
**Purpose:** Validate normal likelihood assumption
**Expected:** nu > 30 (validates Experiment 1)
**Timeline:** If time permits after 1-2-4
**Effort:** 2-3 hours

### 4. Phase 4: Model Assessment (ALWAYS)
**Purpose:** Holistic comparison across all models
**Expected:** LOO stacking, ensemble if similar, final recommendations
**Timeline:** After Phase 3 experiments complete
**Effort:** 2-3 hours

---

## Limitations (Acknowledged)

### Minor Limitations (Not Invalidating):

1. **R-hat at boundary (1.01)**
   - All parameters at or just below threshold
   - All other diagnostics excellent (ESS, visual, LOO)
   - **Assessment:** Noted but not actionable

2. **Tau poorly estimated (SD = 4.21, nearly as large as mean)**
   - 95% CI for tau is [0.03, 13.17] (very wide)
   - **Cause:** Only J=8 studies (variance parameters need large samples)
   - **Assessment:** Data limitation, not model flaw

3. **Prior sensitivity for tau (moderate)**
   - 58% prior-to-posterior SD reduction
   - **Cause:** J=8 insufficient to overwhelm prior
   - **Assessment:** Experiment 4 will quantify (MANDATORY)

4. **Known sigma assumption**
   - Within-study variances treated as fixed
   - **Cause:** Standard meta-analysis assumption
   - **Assessment:** Likely small impact, cannot address without IPD

5. **Small sample (J=8)**
   - Limited power to detect model misspecification
   - **Cause:** Data constraint
   - **Assessment:** Good fit does not rule out all alternatives

6. **Study 5 most influential (k = 0.647)**
   - Only negative effect
   - **Cause:** Most discrepant from pooled mean
   - **Assessment:** k < 0.7, model accommodates adequately

### NOT Limitations (Confirmed Adequate):

- ✅ Convergence: Achieved
- ✅ Normality: Q-Q plot confirms
- ✅ Outliers: All k < 0.7
- ✅ Predictive fit: PPC passes
- ✅ Calibration: SBC validates

---

## Comparison to Alternatives (Preliminary)

**Will be formally compared in Phase 4, but preliminary assessment:**

### vs Experiment 2 (Complete Pooling):
- **Prediction:** Similar mu, narrower CI in Exp 2
- **Expected:** ΔLOO < 4 (models similar), parsimony may favor Exp 2
- **Decision:** Model comparison in Phase 4

### vs Experiment 3 (Robust):
- **Prediction:** Similar results, nu ≈ 30-50
- **Expected:** Normal likelihood validated, Exp 1 preferred (parsimony)
- **Decision:** If nu < 20, prefer Exp 3; else Exp 1

### vs Experiment 4 (Prior Sensitivity):
- **Prediction:** Low mu sensitivity, moderate tau sensitivity
- **Expected:** Ensemble if high sensitivity (|tau_diff| > 5)
- **Decision:** Quantify sensitivity, adjust conclusions

### vs Experiment 5 (Mixture):
- **Prediction:** Mixture collapses, no improvement
- **Expected:** Exp 5 skipped (criteria not met)
- **Decision:** Likely unnecessary

---

## Files and Directories

**This critique directory:**
```
experiments/experiment_1/model_critique/
├── README.md                    # This file (overview)
├── critique_summary.md          # Comprehensive 15-page critique
├── decision.md                  # ACCEPT decision with justification
└── improvement_priorities.md   # Hypothetical improvements (not needed)
```

**Related directories:**
```
experiments/experiment_1/
├── prior_predictive_check/      # Stage 1: Prior validation
├── simulation_based_validation/ # Stage 2: SBC validation (94-95% coverage)
├── posterior_inference/         # Stage 3: Model fitting (R-hat=1.01, ESS adequate)
├── posterior_predictive_check/  # Stage 4: PPC validation (9/9 pass)
└── model_critique/              # Stage 5: THIS DIRECTORY (ACCEPT)
```

---

## How to Use These Documents

**For quick decision:** Read `decision.md` (4 pages)

**For complete justification:** Read `critique_summary.md` (15 pages)

**For hypothetical improvements:** Read `improvement_priorities.md` (5 pages)

**For Phase 4 synthesis:** Combine with Experiments 2-4 results

**For reporting results:**
- Use posterior estimates from `../posterior_inference/`
- Cite validation from SBC and PPC stages
- Acknowledge limitations (small J, tau uncertainty)
- Compare to Experiment 2 (complete pooling)
- Quantify prior sensitivity (Experiment 4)

---

## Contact/Questions

**Model Criticism Specialist (Claude)**
- Date: 2025-10-28
- Version: 1.0
- Status: Complete

**Next actions:**
1. Proceed to Experiment 2 (complete pooling comparison)
2. Proceed to Experiment 4 (prior sensitivity testing)
3. Phase 4: Model assessment and synthesis

---

## Version History

**v1.0 (2025-10-28):** Initial comprehensive critique
- Decision: ACCEPT (conditional)
- All validation stages passed
- Falsification criteria: All passed
- Next: Experiments 2 and 4

---

**End of README**
